Gilead Sciences, Inc. Successfully Completes Tender Offer for Shares of CV Therapeutics, Inc. With Over 88 Percent of Shares Tendered
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) announced today the successful completion of its cash tender offer for all of the outstanding shares of common stock of CV Therapeutics, Inc. (Nasdaq:CVTX). The offer expired as scheduled at one minute following 11:59 p.m., New York City time (midnight), on April 14, 2009.